Observational study suggests heart calcium scans modestly improve cardiovascular risk assessment — Evidence Review
Published in JAMA, by researchers from Northwestern Medicine, Northwestern University Feinberg School of Medicine
Researched by
— the AI search engine for science
Table of Contents
A new study finds that coronary artery calcium scans provide the most value for adults whose heart disease risk is uncertain, rather than those at clearly low or high risk. Most related research supports these findings, showing calcium scoring adds the most clinical information in intermediate or borderline risk groups, though its impact is modest when traditional risk factors are already well characterized using tools like PREVENT (JAMA).
- Multiple large cohort and randomized studies indicate that calcium scoring improves risk stratification primarily in intermediate-risk populations, confirming the new study’s results 2 4 6 7.
- Some studies have shown that calcium scoring can lead to better risk factor management and lifestyle adherence even when event prediction accuracy gains are modest 1 4.
- Comprehensive screening or routine use of calcium scans in low-risk groups offers limited benefit and may increase unnecessary interventions, aligning with the current study’s conclusions 3 10 11.
Study Overview and Key Findings
Coronary artery calcium (CAC) scans have grown in popularity for refining cardiovascular risk assessment. However, determining who benefits most from this imaging test is an ongoing question in clinical practice. The recent study led by Northwestern Medicine aimed to clarify the added value of CAC scoring when used alongside the PREVENT risk calculator, a widely adopted tool based on standard health metrics.
The study’s significance lies in its large, diverse sample and its focus on practical clinical implications—specifically, whether CAC scans change management decisions when used in addition to established risk calculators. The findings suggest that while CAC scans can reclassify risk for some patients, their value is concentrated among those with uncertain, borderline, or intermediate risk.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | Northwestern Medicine, Northwestern University Feinberg School of Medicine |
| Journal Name | JAMA |
| Authors | Xiaoning Huang, Lucia C. Petito, Norrina B. Allen, Ron Blankstein, Roger S. Blumenthal, Josef Coresh, Philip Greenland, Jennifer E. Ho, Amit Khera, Donald M. Lloyd-Jones, Janani Rangaswami, James H. Stein, Chiadi E. Ndumele, Sadiya S. Khan, Nilay S. Shah |
| Population | Adults aged 45 to 79 |
| Sample Size | n=6000 |
| Methods | Observational Study |
| Outcome | Cardiovascular event risk assessment |
| Results | Calcium scores modestly improved risk prediction from 0.73 to 0.75. |
Literature Review: Related Studies
To assess how this new study fits into the broader scientific context, we searched the Consensus database (covering over 200 million papers) using the following queries:
- heart calcium scan benefits
- calcium score risk prediction improvement
- populations benefiting heart calcium screening
Summary Table of Major Topics and Key Findings
| Topic | Key Findings |
|---|---|
| Which populations benefit most from coronary artery calcium (CAC) scanning? | - CAC scanning is most valuable in individuals with intermediate or borderline risk, improving risk stratification and guiding preventive care 2 4 6 7. - Routine use in low-risk or high-risk groups offers little additional benefit and may lead to unnecessary interventions 3 10 11. |
| Does CAC scoring improve prediction of cardiovascular events beyond traditional risk factors? | - Adding CAC to standard risk models (e.g., Framingham, PREVENT) modestly improves event prediction, especially in those not clearly low or high risk 2 3 6 7 8. - The net reclassification index and C-statistics improve primarily in intermediate-risk populations 6 7 8. |
| What are the practical impacts of CAC scanning on clinical management and outcomes? | - CAC scanning can improve risk factor control and medication/lifestyle adherence without significantly increasing downstream testing 1 4. - Comprehensive screening in asymptomatic general populations has not shown clear mortality benefit 10. |
| How does CAC scoring influence preventive treatment decisions? | - CAC scoring can help identify individuals who may benefit from statins or aspirin in primary prevention, particularly when bleeding risk is low and ASCVD risk is not low 5. - CAC scoring reduces the number of individuals recommended for preventive therapy compared to risk models alone 11. |
Which populations benefit most from coronary artery calcium (CAC) scanning?
Research consistently demonstrates that CAC scanning confers the greatest benefit in individuals with an uncertain risk of cardiovascular events—typically those in the borderline or intermediate-risk categories by standard calculators. The new study reinforces this, showing that CAC scans modestly but meaningfully reclassify risk in these groups, while offering little additional value for those already at low or high risk 2 4 6 7.
- CAC scanning is particularly effective for refining risk estimates in intermediate-risk individuals, potentially altering treatment decisions 2 4 6 7.
- In low-risk populations, such as younger adults or low-risk women, CAC presence correlates with higher event rates, but the incremental predictive value is modest and may not justify routine scanning 3.
- High-risk individuals typically warrant preventive treatment regardless of CAC findings, limiting the scan’s clinical utility in this group 11.
- Large-scale trials show that population-wide screening with CAC does not significantly reduce overall mortality, supporting targeted rather than universal use 10.
Does CAC scoring improve prediction of cardiovascular events beyond traditional risk factors?
While the incremental gain is often modest, CAC scoring does improve the accuracy of predicting cardiovascular events beyond traditional risk factor models. This is especially true in those whose risk is not definitively low or high at baseline.
- Studies show that adding CAC to models like Framingham or PREVENT increases the C-statistic and improves the net reclassification index, particularly in intermediate-risk groups 6 7 8.
- In older adults, CAC score may outperform age as a discriminator between lower and higher risk, though the added benefit for stroke prediction is less clear 8.
- In women classified as low risk by traditional scores, CAC presence is associated with higher event rates and modest improvements in prediction 3.
- The improvement in event prediction is most clinically relevant when it influences subsequent management decisions 2 6 7.
What are the practical impacts of CAC scanning on clinical management and outcomes?
CAC scanning has been shown to improve clinical management by motivating better risk factor control and adherence to lifestyle changes or medications, without significantly increasing unnecessary testing.
- Randomized trials indicate that knowing one’s CAC score leads to superior control of blood pressure, cholesterol, and weight, as well as better maintenance of overall risk scores 1 4.
- CAC results can reinforce or reduce the intensity of preventive interventions, helping tailor care to individual risk 1 4.
- Despite these benefits in risk factor modification, comprehensive CAC-based screening in asymptomatic populations has not demonstrated a significant reduction in all-cause mortality over five years 10.
- Resource utilization may be optimized as CAC scoring can reduce overtreatment in low-risk individuals while focusing interventions on those most likely to benefit 11.
How does CAC scoring influence preventive treatment decisions?
CAC scoring can help clinicians decide who should start statin or aspirin therapy for primary prevention, particularly in cases where bleeding risks are low and the baseline risk is not low.
- Higher CAC scores are associated with greater estimated benefit from aspirin, but only in those with at least borderline risk and low bleeding risk 5.
- CAC scoring leads to a reduction in the number of people indicated for preventive treatment compared to traditional risk models, focusing therapy on those with demonstrable calcification 11.
- The ability to reclassify risk using CAC can help avoid unnecessary medication in low-risk individuals and prompt timely intervention in those at higher risk 5 11.
- Emerging evidence suggests the need for individualized assessment, as the benefit-risk balance may vary across populations and subgroups 5 11.
Future Research Questions
Despite advances in risk prediction and stratification, several questions remain regarding the optimal use of CAC scanning. Future research is needed to clarify its role in specific populations, evaluate cost-effectiveness, and determine the impact on long-term outcomes and clinical decision-making.
| Research Question | Relevance |
|---|---|
| How does coronary calcium scoring impact long-term cardiovascular outcomes in diverse populations? | Diverse ethnic and age groups may have different risk profiles and responses to CAC-guided interventions, which are not fully addressed in current studies 6 8. |
| What is the cost-effectiveness of targeted vs routine CAC screening in primary prevention? | Widespread CAC screening may increase costs and resource use; targeted strategies could optimize benefits while limiting unnecessary testing 10 11. |
| Can serial CAC scans guide treatment modification and improve outcomes? | The value of repeat CAC scanning to monitor progression, assess treatment efficacy, or prompt therapy changes has not been established 4 9. |
| Does adding CAC scoring to risk models improve decision-making for statin or aspirin therapy in primary prevention? | More evidence is needed to determine whether CAC scoring leads to better allocation of preventive therapies and improved real-world outcomes 5 11. |
| What are the risks of incidental findings or overdiagnosis with CAC scanning in low-risk patients? | Routine scanning in low-risk groups may lead to unnecessary follow-up, anxiety, or interventions without clear benefit, highlighting the need to quantify potential harms 3 10 11. |